5
Views
0
CrossRef citations to date
0
Altmetric
Invited Papers

Intestinal Transplantation: from the Laboratory to the Clinics

, , , , , , , & show all
Pages 52-57 | Published online: 11 Mar 2016

References

  • Fortner J. G., Shiu M. H., Kunlin A. et al. Orthotopic intestinal allografting after massive intestinal resection. Bull Soc Int Chir, 1972, 31: 264–71.
  • Ruiz J. O., Lillehei R. C. Intestinal transplantation. Am J Proctol, 1972, 23: 379–93.
  • Ruiz J. O., Lillehei R. C. Intestinal transplantation. Surg Clin North Am, 1972, 52: 1075–91.
  • Calne R. Cyclosporine as a milestone in Immunosuppression. Transplant Proc, 2004, 36 (supplement 2): 13S-15S.
  • Ruemmele F. M., Sauvat F., Colomb V. et al. Seventeen years after successful small bowel transplantation: long term graft acceptance without immune tolerance. Gut, 2006, 55: 903–4.
  • Abu-Elmagd K., Reyes J., Todo S. et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. JAm Coll Surg, 1998, 186: 512–25.
  • Selvaggi G., Tzakis A. G. Intestinal and multivisceral transplantation: future perspectives. Front Biosci, 2007, 12: 4742–54.
  • Pironi L., Hebuterne X., Van Gossum A. et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol, 2006, 101: 1633–43.
  • Schena S., Testa G., Setty S., Abcarian H., Benedetti E. Successful identical-twin living donor small bowel transplant for necrotizing enterovasculitis secondary to Churg-Strauss syndrome. Transpl Int, 2006,, 19: 594–7.
  • Pirenne J., D’Silva M., Degiovanni G., Jacquet N., Dunn D. L. Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantation. Transpl Int, 1993, 6: 258–62.
  • Bond G. J., Mazariegos G. V., Sindhi R., Abu-Elmagd K.M., Reyes J. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg, 2005, 40: 2749.
  • Sudan D. L. Treatment of intestinal failure: intestinal transplantation. Nat Clin Pract Gastroenterol Hepatol, 2007, 4: 503–10.
  • Selvaggi G., Gaynor J. J., Moon J. et al. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. Am J Transplant, 2007, 7: 1249–57.
  • Pirenne J., Kawai M. Tolerogenic protocols for intestinal transplantation. Transpl Immunol, 2004, 13: 131–7.
  • Margreiter R. Development and importance of combined organ transplantation. Langenbecks Arch Chir Suppl Kongressbd, 1992, 224–7.
  • Pirenne J., Kawai M. The protective effect of the liver: does it apply to the bowel too ? Transplantation, 2006, 81: 978–9.
  • Pirenne J., Gruessner A. C., Benedetti E. et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. Surgery, 1997, 121: 79–88.
  • Fudaba Y., Spitzer T. R., Schaffer J. et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant, 2006, 6: 2121–33.
  • Donckier V., Troisi R., Le Moine A. et al. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl, 2006, 12: 1523–8.
  • Orloff S. L., Yin Q., Corless C. L., Orloff M. S., Rabkin J. M., Wagner C. R. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. Transplantation, 2000, 69: 1295303.
  • Wood K. J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol, 2003, 3: 199–210.
  • Pirenne J., Kawai M. Tolerogenic protocol for intestinal transplantation. Transplant Proc, 2006, 38: 1664–7.
  • Pirenne J., Koshiba T., Geboes K. et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low Immunosuppression. Transplantation, 2002, 73: 966–8.
  • Kitade H., Kawai M., Rutgeerts O. et al. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol, 2005, 175: 4963–70.
  • Koshiba T., Van Damme B., Ji P. et al. Addition of steroids blocks the tolerogenic potential of donor-specific blood transfusion. Transplant Proc, 2001, 33: 375–6.
  • Kawai M., Kitade H., Mathieu C., Waer M., Pirenne J. Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation, 2005, 79: 1073–7.
  • Kawai M., Kitade H., Mathieu C., Waer M., Pirenne J. Addition of a “danger” signal blocks tolerance induction after donor-specific blood transfusion (abstract). Am J Transplant, 2006, Supplement WTC: 605–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.